Jaguar Health Announced Magdalena Biosciences Initiates Preclinical Study To Evaluate Plant Extracts To Treat Depression, Anxiety, ADHD And Other Mental Health Indications
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health and Filament Health Corp.'s joint venture, Magdalena Biosciences, has initiated a preclinical study to evaluate plant extracts for the treatment of depression, anxiety, ADHD, and other mental health indications.
October 23, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jaguar Health's joint venture, Magdalena Biosciences, is initiating a preclinical study on plant extracts for mental health treatment, which could potentially lead to new product developments.
The news directly pertains to Jaguar Health as it is a joint venture with Filament Health Corp. The initiation of the preclinical study indicates progress in their research and development efforts, which could potentially lead to new product developments. This could have a positive impact on Jaguar Health's stock in the short term as it indicates potential growth opportunities.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100